JPWO2021236854A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021236854A5 JPWO2021236854A5 JP2022571114A JP2022571114A JPWO2021236854A5 JP WO2021236854 A5 JPWO2021236854 A5 JP WO2021236854A5 JP 2022571114 A JP2022571114 A JP 2022571114A JP 2022571114 A JP2022571114 A JP 2022571114A JP WO2021236854 A5 JPWO2021236854 A5 JP WO2021236854A5
- Authority
- JP
- Japan
- Prior art keywords
- sars
- cov
- seq
- set forth
- spike
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063027283P | 2020-05-19 | 2020-05-19 | |
| US63/027,283 | 2020-05-19 | ||
| US202063047789P | 2020-07-02 | 2020-07-02 | |
| US63/047,789 | 2020-07-02 | ||
| US202163139292P | 2021-01-19 | 2021-01-19 | |
| US63/139,292 | 2021-01-19 | ||
| PCT/US2021/033275 WO2021236854A1 (en) | 2020-05-19 | 2021-05-19 | Sars-cov-2 vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023526495A JP2023526495A (ja) | 2023-06-21 |
| JPWO2021236854A5 true JPWO2021236854A5 (https=) | 2024-05-27 |
| JP2023526495A5 JP2023526495A5 (https=) | 2024-05-27 |
Family
ID=78707614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022571114A Pending JP2023526495A (ja) | 2020-05-19 | 2021-05-19 | ＳＡＲＳ－ＣｏＶ－２ワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230330215A1 (https=) |
| EP (1) | EP4153730A4 (https=) |
| JP (1) | JP2023526495A (https=) |
| KR (1) | KR20230025670A (https=) |
| CN (1) | CN116437951A (https=) |
| AU (1) | AU2021273827A1 (https=) |
| CA (1) | CA3178115A1 (https=) |
| IL (1) | IL297795A (https=) |
| WO (1) | WO2021236854A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12194089B2 (en) | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| AU2021323389B1 (en) * | 2020-11-12 | 2022-03-24 | Ahs Hospital Corp. | SARS-CoV-2 immunodominant peptide constructs and uses thereof |
| US20240156946A1 (en) | 2020-12-22 | 2024-05-16 | CureVac SE | Rna vaccine against sars-cov-2 variants |
| US20240409587A1 (en) * | 2021-04-12 | 2024-12-12 | La Jolla Institute For Immunology | Coronavirus T Cell Epitopes and Uses Thereof |
| WO2022268916A2 (en) * | 2021-06-23 | 2022-12-29 | Ose Immunotherapeutics | Pan-coronavirus peptide vaccine |
| WO2023081936A2 (en) * | 2021-11-08 | 2023-05-11 | Gritstone Bio, Inc. | Sars-cov-2 vaccines |
| CN116212012A (zh) * | 2021-12-02 | 2023-06-06 | 上海泽润生物科技有限公司 | 复合佐剂以及包含它的疫苗制剂 |
| WO2023100159A2 (en) * | 2021-12-03 | 2023-06-08 | Kashiv Biosciences, Llc | Multicistron expression vector for covid-19 vaccine |
| TWI845133B (zh) * | 2022-01-27 | 2024-06-11 | 中央研究院 | 胜肽介導的活性劑遞送 |
| CN114832099B (zh) * | 2022-04-08 | 2023-11-28 | 国科宁波生命与健康产业研究院 | 一种用于治疗SARS-CoV-2变异毒株感染的多肽制剂 |
| CN114907453B (zh) * | 2022-04-08 | 2023-07-25 | 国科宁波生命与健康产业研究院 | 一种用于治疗SARS-CoV-2病毒感染的S蛋白多肽 |
| US12084703B2 (en) | 2022-05-12 | 2024-09-10 | SunVax mRNA Therapeutics Inc. | Synthetic self-amplifying mRNA molecules with secretion antigen and immunomodulator |
| CN119677546A (zh) * | 2022-07-12 | 2025-03-21 | 吉利德科学公司 | Hiv免疫原性多肽和疫苗及其用途 |
| WO2024026553A1 (en) * | 2022-08-03 | 2024-02-08 | Centre Hospitalier De L'université De Montréal | Novel antigenic epitope against sars-cov-2 and uses thereof |
| CN119907804A (zh) * | 2022-09-19 | 2025-04-29 | 百奥泰生物制药股份有限公司 | 一种冠状病毒多价疫苗及其应用 |
| WO2024089638A1 (en) | 2022-10-28 | 2024-05-02 | Glaxosmithkline Biologicals Sa | Nucleic acid based vaccine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2729116C2 (ru) * | 2015-12-16 | 2020-08-04 | Гритстоун Онколоджи, Инк. | Идентификация, производство и применение неоантигенов |
-
2021
- 2021-05-19 CN CN202180049931.9A patent/CN116437951A/zh active Pending
- 2021-05-19 JP JP2022571114A patent/JP2023526495A/ja active Pending
- 2021-05-19 KR KR1020227044348A patent/KR20230025670A/ko active Pending
- 2021-05-19 AU AU2021273827A patent/AU2021273827A1/en active Pending
- 2021-05-19 IL IL297795A patent/IL297795A/en unknown
- 2021-05-19 EP EP21808924.1A patent/EP4153730A4/en active Pending
- 2021-05-19 CA CA3178115A patent/CA3178115A1/en active Pending
- 2021-05-19 WO PCT/US2021/033275 patent/WO2021236854A1/en not_active Ceased
-
2022
- 2022-11-18 US US18/057,171 patent/US20230330215A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525076A5 (https=) | ||
| JPWO2019226941A5 (https=) | ||
| JPWO2021236854A5 (https=) | ||
| JP2021524247A5 (https=) | ||
| RU2019119272A (ru) | Вирусная доставка неоантигенов | |
| JP2021525076A (ja) | 共有抗原 | |
| JP2022512912A (ja) | アルファウイルス新生抗原ベクター及びインターフェロン阻害因子 | |
| JP2021524247A (ja) | 免疫チェックポイント阻害剤の共発現ベクター | |
| JP2010254711A (ja) | キメラアルファウイルスレプリコン粒子 | |
| McAllister et al. | Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases | |
| JPH09511143A (ja) | アルファーウイルスｃＤＮＡベクター | |
| JP2003520597A (ja) | 組換えフラビウイルスおよびその使用方法 | |
| BR112015023524B1 (pt) | Vírus vaccinia ankara modificado, composição compreendendo o dito vírus e uso do mesmo para primagem ou reforço de uma resposta imune | |
| EP4175721A1 (en) | Prostate neoantigens and their uses | |
| JP2004501646A5 (https=) | ||
| US20240294884A1 (en) | Vaccines based on mutant calr and jak2 and their uses | |
| JPWO2019226939A5 (https=) | ||
| JPWO2022032196A5 (https=) | ||
| JPWO2020097393A5 (https=) | ||
| JPWO2020243719A5 (https=) | ||
| CA3170843A1 (en) | Neoantigens expressed in multiple myeloma and their uses | |
| JPWO2021003348A5 (https=) | ||
| CN120888569A (zh) | 一种自复制mRNA疫苗及其制备方法和用途 | |
| JPWO2021216776A5 (https=) | ||
| JPWO2021203104A5 (https=) |